|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2010-5-20
|
|
pubmed:abstractText |
The aim was to investigate whether germline polymorphisms within candidate genes known or suspected to be involved in fluorouracil (FU), oxaliplatin, and irinotecan pathways were associated with toxicity and clinical outcome in patients with metastatic colorectal cancer (mCRC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BarroisMichelM,
pubmed-author:BeaunePhilippeP,
pubmed-author:BoigeValérieV,
pubmed-author:BouchéOlivierO,
pubmed-author:CastaingMarineM,
pubmed-author:DucreuxMichelM,
pubmed-author:Laurent-PuigPierreP,
pubmed-author:Le CorreDelphineD,
pubmed-author:LoriotMarie-AnneMA,
pubmed-author:MalkaDavidD,
pubmed-author:MendiboureJeanJ,
pubmed-author:MiranIsabelleI,
pubmed-author:MulotClaireC,
pubmed-author:PignonJean-PierreJP,
pubmed-author:TrégouëtDavid-AlexandreDA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2556-64
|
|
pubmed:dateRevised |
2011-6-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20385995-Adult,
pubmed-meshheading:20385995-Aged,
pubmed-meshheading:20385995-Aged, 80 and over,
pubmed-meshheading:20385995-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20385995-Camptothecin,
pubmed-meshheading:20385995-Colorectal Neoplasms,
pubmed-meshheading:20385995-Disease-Free Survival,
pubmed-meshheading:20385995-Female,
pubmed-meshheading:20385995-Fluorouracil,
pubmed-meshheading:20385995-Genotype,
pubmed-meshheading:20385995-Humans,
pubmed-meshheading:20385995-Leucovorin,
pubmed-meshheading:20385995-Male,
pubmed-meshheading:20385995-Middle Aged,
pubmed-meshheading:20385995-Neoplasm Staging,
pubmed-meshheading:20385995-Organoplatinum Compounds,
pubmed-meshheading:20385995-Pharmacogenetics,
pubmed-meshheading:20385995-Polymorphism, Genetic,
pubmed-meshheading:20385995-Prospective Studies,
pubmed-meshheading:20385995-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05.
|
|
pubmed:affiliation |
Department of Medicine, Institut Gustave-Roussy, Villejuif, France. boige@igr.fr
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
